Inhibrx Biosciences, Inc. (INBX)
109.35
+4.62
(+4.41%)
USD |
NASDAQ |
Sep 18, 16:00
109.58
+0.23
(+0.21%)
After-Hours: 20:00
Inhibrx Biosciences Price : 109.35 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 106.45 | 110.41 | 105.04 | 109.35 | 483377.0 |
| Sep 17, 2026 | 103.73 | 108.00 | 103.73 | 104.73 | 217279.0 |
| Sep 16, 2026 | 105.61 | 106.44 | 99.06 | 101.77 | 363492.0 |
| Sep 15, 2026 | 109.44 | 109.44 | 104.84 | 105.61 | 251603.0 |
| Sep 14, 2026 | 109.10 | 111.44 | 104.90 | 110.47 | 239992.0 |
| Sep 11, 2026 | 113.00 | 115.11 | 108.93 | 109.27 | 211017.0 |
| Sep 10, 2026 | 109.23 | 113.95 | 107.22 | 111.42 | 313889.0 |
| Sep 09, 2026 | 117.38 | 128.54 | 112.03 | 112.86 | 677825.0 |
| Sep 08, 2026 | 117.22 | 120.18 | 94.00 | 114.34 | 1.677M |
| Sep 04, 2026 | 121.04 | 124.19 | 120.48 | 121.17 | 196513.0 |
| Sep 03, 2026 | 125.20 | 126.00 | 120.17 | 122.26 | 151714.0 |
| Sep 02, 2026 | 125.61 | 127.75 | 121.25 | 124.97 | 189886.0 |
| Sep 01, 2026 | 124.98 | 129.88 | 120.62 | 124.66 | 275907.0 |
| Aug 31, 2026 | 123.39 | 128.87 | 121.59 | 126.70 | 388975.0 |
| Aug 28, 2026 | 123.80 | 126.04 | 119.38 | 123.41 | 241483.0 |
| Aug 27, 2026 | 124.27 | 127.34 | 122.36 | 123.93 | 310883.0 |
| Aug 26, 2026 | 123.00 | 131.01 | 119.44 | 125.34 | 302858.0 |
| Aug 25, 2026 | 105.50 | 126.50 | 104.71 | 122.72 | 510619.0 |
| Aug 24, 2026 | 105.00 | 105.14 | 94.20 | 104.94 | 373620.0 |
| Aug 21, 2026 | 100.76 | 105.65 | 99.05 | 103.63 | 220745.0 |
| Aug 20, 2026 | 98.65 | 102.50 | 96.56 | 99.15 | 351489.0 |
| Aug 19, 2026 | 96.01 | 102.25 | 95.27 | 101.48 | 310658.0 |
| Aug 18, 2026 | 89.83 | 94.89 | 89.00 | 94.62 | 311231.0 |
| Aug 17, 2026 | 87.06 | 92.99 | 85.06 | 92.01 | 231742.0 |
| Aug 14, 2026 | 91.80 | 96.06 | 87.01 | 88.37 | 268290.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AnaptysBio, Inc. | 55.20 |
| 4D Molecular Therapeutics, Inc. | 15.22 |
| Design Therapeutics, Inc. | 12.24 |
| Agenus, Inc. | 7.85 |
| Amgen, Inc. | 385.65 |
Price Related Metrics
| Earnings Yield | -8.12% |
| Market Cap | 1.608B |